Evidence map›Paper›PMID 30835931›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Controllable Isomerization of Alkenes by Dual Visible-Light-Cobalt Catalysis.

Qing-Yuan Meng, Tobias E Schirmer, Kousuke Katou, Burkhard König

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. PotassiumACS omega · 2026
    Article
  2. Article
  3. Article
  4. HighlyThe Journal of organic chemistry · 2025
    Article
  5. Article
  6. Article
  7. NJACS Au · 2024
    Article
  8. Article
  9. Article
  10. A Neutral PCThe Journal of organic chemistry · 2024
    Article
  11. Article
  12. B(CChemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qing-Yuan MengInstitute of Organic Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, 93040, Regensburg, Germany.
Tobias E SchirmerInstitute of Organic Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, 93040, Regensburg, Germany.
Kousuke KatouInstitute of Transformative Bio-Molecules (WPI-ITbM) and Department of Molecular and Macromolecular Chemistry, Graduate School of Engineering, Nagoya University, Nagoya, 464-8601, Japan.
Burkhard KönigInstitute of Organic Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, 93040, Regensburg, Germany.ORCID http://orcid.org/0000-0002-6131-4850

Funding

Deutsche Forschungsgemeinschaft GRK 1626; KO 1537/18-1H2020 European Research Council No. 741623
6 · The paper itself

Abstract

We report herein that thermodynamic and kinetic isomerization of alkenes can be accomplished by the combination of visible light with Co catalysis. Utilizing Xantphos as the ligand, the most stable isomers are obtained, while isomerizing terminal alkenes over one position can be selectively controlled by using DPEphos as the ligand. The presence of the donor-acceptor dye 4CzIPN accelerates the reaction further. Transformation of exocyclic alkenes into the corresponding endocyclic products could be efficiently realized by using 4CzIPN and Co(acac)

Indexed as

alkene isomerizationcobaltphotosynthesisvisible light catalysis

Identifiers

PMID30835931
PMCPMC6519376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.